Home  > 
  Chugai Pharma's anti-influenza drug Tamiflu dry syrup 3% gets Japanese nod for additional dosage and administration for newborns & infants,   March 24, 2017
  US FDA accepts Tarrex Biopharma's IND application to begin clinical trial of TX803 for colorectal cancer treatment,   March 24, 2017
  Alexion seeks Japanese approval for Soliris to treat patients with refractory generalized myasthenia gravis,   March 24, 2017
  US FDA approves Alcon's AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with Activefocus design for uncompromised distance vision, presbyopia correction,   March 24, 2017
  US FDA grants fast track status to Shire’s recombinant ADAMTS13 to treat acute episodes of hTTP,   March 23, 2017
  Sound Pharma gets $1.6 million award from CFFT to prevent hearing loss, tinnitus associated with antibiotic use,   March 23, 2017
  Avista Pharma completes expansion of contract testing facility in Agawam, Massachusetts,   March 23, 2017
  US FDA approves Newron Pharma's Xadago tablets to treat Parkinson’s disease,   March 23, 2017
  Novocure’s second generation Optune receives Japanese approval,   March 22, 2017
  Bausch + Lomb, Nicox announce PDUFA date for novel glaucoma candidate latanoprostene bunod,   March 22, 2017
  US FDA grants RMAT designation to Humacyte's Humacyl in vascular access for hemodialysis,   March 22, 2017
  Immune gets Dominican Republic Ministry of Public Health approval to export Lodonal to Kenya,   March 21, 2017
  US FDA approves Mylan’s TLE400 under PEPFAR,   March 21, 2017
  VolitionRx forms wholly-owned US subsidiary, Volition America, Inc,   March 21, 2017
  US FDA issues Complete Response Letter to ZS Pharma's sodium zirconium cyclosilicate for hyperkalaemia,   March 18, 2017
  European Commission approves label extension of Shire’s Cinryze to treat children with Hereditary angiodema,   March 17, 2017
  Agena Bioscience launches new lung and colon cancer panels for detection of somatic mutations from liquid biopsies, solid tumor tissues,   March 17, 2017
  TA Associates completes investment in Mumbai-based Ideal Cures,   March 16, 2017
  Endo announces US FDA advisory committee’s vote on Opana ER,   March 16, 2017
  Japanese MHLW grants priority review status for AbbVie’s HCV regimen of glecaprevir/pibrentasvir to treat genotypes of chronic hepatitis C,   March 16, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |